About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

   About Us: Medical Advisory Board

 
 

2/28/2014 - Daxor Corporation Announces Filing of Form N-CSR for December 31, 2013

  

2/11/2014 - Daxor Corporation Announces Dr. Joseph Feldschuh, President and CEO, Sustained a Fractured Hip, Had Emergency Surgery, and Received a Transfusion of His Own Frozen Blood Which Had Been Stored Four Years Ago

  

1/15/2014 - Daxor Announces a Research Study That Proves Micro Samples are Feasible for Accurate Blood Volume Measurements on Infants and Small Children Utilizing the BVA-100 Blood Volume Analyzer

  
 

______________________

 
     
  Form N-CSR for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  
  Form N-CSR for June 30, 2013  
  Form N-Q for Mar 31, 2013  
 
    Menu Options

Home Page

Executive Team

Board of Directors

Contact Us

Company

Careers

 

 

 

 

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

Philip Frost, M.D., Chairman of DAXOR's Medical Advisory Board

Dr. Frost has served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation since 1987 and as President of IVAX Corporation from July 1991 until January 1995. He was Chairman of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida, from 1972 to 1990. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc., from 1972 to 1986; Vice Chairman of the Board of North American Vaccine, Inc., from 1989 to 2000; and Chairman of the Board of Directors of Continucare Corporation from 1996 to 2002. Dr. Frost currently serves as Chairman of the Board of Directors of Whitman Education Group, Inc., and as a Director of Northrop Grumman Corp. He is also Chairman of the Board of Trustees of the University of Miami and a member of the Board of Governors of the American Stock Exchange. Dr. Frost is a distinguished scientist who played a key role in the development of skin patch administration of medications and is a highly successful businessman.

Robert L. Rosenthal, M.D.

Dr. Rosenthal was the Chief of Hematology, Blood Bank Director, and attending physician at North General Hospital in New York City for 41 years. He was an Associate Clinical Professor of Medicine, Mount Sinai School of Medicine. Dr. Rosenthal has directed and performed extensive research on blood coagulation, hemorrhagic and thromboembolic diseases, leukemia and Gaucher's Disease. Dr. Rosenthal discovered Factor XI, and the hemorrhagic disease caused by its deficiency. He also published the first description of Acute Promyelocytic Leukemia. Dr. Rosenthal has published 70 papers.

Fred Gilbert, M.D.

Dr. Gilbert is the Director of Human Cancer Genetics, Strang Cancer Prevention Center, New York, NY, as well as co-Director of the Division of Human Genetics, and the Director of the DNA Diagnosis Laboratory at Cornell University Medical Center, New York, NY. Dr. Gilbert received his undergraduate degree from MIT in biology and earned his medical degree from Albert Einstein College of Medicine. He is the author of over 80 original medical papers.

James H. Brassel, M.D.

James H. Brassel, M.D. is Associate Director of Laboratories at North Shore Hospital. He is a former Director of Blood Banking at Columbia Presbyterian Medical Center. He was the initial director of Idant Blood Bank, a subsidiary of the DAXOR Corporation, the first independent laboratory in the U.S. dedicated to long term storage of an individual's frozen blood.


© 2014 DAXOR Corporation. All Rights Reserved.